CEO Roundtable: Life-science companies counter COVID, face supply-chain instability
Northern Colorado life sciences companies feel the supply chain crunch as parts and packaging struggle to make their way to where they’re needed.
Industry leaders who joined BizWest’s CEO Roundtable on life sciences Tuesday expressed concerns over rising costs and wait times.
“We are a brand company and our brand is very well known,” Growcentia Inc. CEO Scott Wiley said about the impact supply-chain issues have had on the biotechnology company’s branding.
“The more constraining pinch has been in packaging materials. Bottles, plastic bottles are really hard to get,” Wiley said.
ALS Global Ltd. lab director Shiloh Summy is more optimistic about the effects…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Enliven Therapeutics finished the third quarter with $292 million in cash, which, the company said,…
-
Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
Arca Biopharma has completed its merger with Oruka Therapeutics Inc.
